NFE2L2 and viral infectious disease: Importantly, they also demonstrated that enhancing Nrf2 activation via supplementation with sulforaphane (SFN) and epigallocatechin gallate (EGCG) increased antiviral mediators in the absence of viral infection and also abrogated viral entry.